Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T18278 |
Mal-PEG2-VCP-Eribulin
|
Others | Others |
Mal-PEG2-VCP-Eribulin is a chemotherapeutic compound comprising an antibody-drug conjugate (ADC) linker (Mal-PEG2-VCP) and the microtubule inhibitor Eribulin[1]. This compound uniquely targets microtubules, offering a novel approach to cancer treatment. Eribulin is specifically utilized in creating targeted Eribulin-based drugs for antibody conjugates[1]. |